相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer
Kalevi Kairemo et al.
DIAGNOSTICS (2020)
Reliability of dopamine transporter PET measurements with [18F]FE-PE2I in patients with Parkinson's disease
Vera S. Kerstens et al.
EJNMMI RESEARCH (2020)
Dealing with PET radiometabolites
Krishna Kanta Ghosh et al.
EJNMMI RESEARCH (2020)
PET technology for drug development in psychiatry
Ryosuke Arakawa et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial
Lucia Zanoni et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity
Anton Lindberg et al.
EJNMMI RESEARCH (2019)
Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects
Mohammad Mahdi Moein et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2019)
The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development
Tohru Takebe et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model
Freddy E. Escorcia et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Serotonin concentration enhancers at clinically relevant doses reduce [11C] AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain
Kai-Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2018)
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
Mickael Huiban et al.
MOLECULAR IMAGING AND BIOLOGY (2017)
18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi
Jessica Lohrke et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers
Austin R. Pantel et al.
CANCER LETTERS (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Antibody Approaches To Treat Brain Diseases
Vera Neves et al.
TRENDS IN BIOTECHNOLOGY (2016)
Pitfalls and Limitations of PET/CT in Brain Imaging
Eric Salmon et al.
SEMINARS IN NUCLEAR MEDICINE (2015)
Brain PET in the Diagnosis of Alzheimer's Disease
Charles Marcus et al.
CLINICAL NUCLEAR MEDICINE (2014)
The role of molecular imaging in modern drug development
Lidia Cunha et al.
DRUG DISCOVERY TODAY (2014)
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL
Ken Herrmann et al.
ONCOTARGET (2014)
Methods for Radiolabelling of Monoclonal Antibodies
Vladimir Tolmachev et al.
HUMAN MONOCLONAL ANTIBODIES: METHODS AND PROTOCOLS (2014)
Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status
Idris Bahce et al.
CLINICAL CANCER RESEARCH (2013)
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers
Alberto Biggi et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Performance of FDG PET/CT in the Clinical Management of Breast Cancer
David Groheux et al.
RADIOLOGY (2013)
Positron Emission Tomography as a Method for Measuring Drug Delivery to Tumors in vivo: The Example of [C-11]docetaxel.
Astrid A. M. van der Veldt et al.
FRONTIERS IN ONCOLOGY (2013)
Positron emission tomography molecular imaging for drug development
Paul M. Matthews et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
LMI1195 PET imaging in evaluation of regional cardiac sympathetic denervation and its potential role in antiarrhythmic drug treatment
Ming Yu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Radioligand Binding to Brain Dopamine and Serotonin Receptors and Transporters in Parkinson's Disease: Relation to Gene Polymorphisms
Cuneyt Guzey et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2012)
Impaired cognition in bipolar I disorder: The roles of the serotonin transporter and brain-derived neurotrophic factor
Yuan-Hwa Chou et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship
Euitae Kim et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging
Sonia Lavisse et al.
JOURNAL OF NEUROSCIENCE (2012)
Radiosynthesis and Preclinical Evaluation of 18F-F13714 as a Fluorinated 5-HT1A Receptor Agonist Radioligand for PET Neuroimaging
Laetitia Lemoine et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Affinity and selectivity of [11C]-(+)-PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo
Jean-Dominique Gallezot et al.
SYNAPSE (2012)
Determination of drug-receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance
Georges Vauquelin
MEDCHEMCOMM (2012)
PET imaging for receptor occupancy: meditations on calculation and simplification
Yumin Zhang et al.
JOURNAL OF BIOMEDICAL RESEARCH (2012)
Approaches using molecular imaging technology - use of PET in clinical microdose studies
Claudia C. Wagner et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000-2009
K. I. Kaitin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Quantitative analysis of [C-11]AZ10419369 binding to 5-HT1B receptors in human brain
Katarina Varnas et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Key Concepts of Clinical Trials: A Narrative Review
Craig A. Umscheid et al.
POSTGRADUATE MEDICINE (2011)
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369
Katarina Varnas et al.
PSYCHOPHARMACOLOGY (2011)
Toward Molecular Imaging-Driven Drug Development in Oncology
Elisabeth G. E. de Vries et al.
CANCER DISCOVERY (2011)
Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist
Graham Searle et al.
BIOLOGICAL PSYCHIATRY (2010)
Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting β-Amyloid
V. Frisardi et al.
CURRENT ALZHEIMER RESEARCH (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
PET radiotracers: crossing the blood-brain barrier and surviving metabolism
Victor W. Pike
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer
Noriaki Sunaga et al.
LUNG CANCER (2008)
[11C]AZ10419369:: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET).: Characterization in the primate brain
M. Edward Pierson et al.
NEUROIMAGE (2008)
Antipsychotic efficacy:: Relationship to optimal D2-receptor occupancy
Luca Pani et al.
EUROPEAN PSYCHIATRY (2007)
Estimating the cost of new drug development: Is it really $802 million?
CP Adams et al.
HEALTH AFFAIRS (2006)
PET tracers for imaging of the dopaminergic system
Philip H. Elsinga et al.
CURRENT MEDICINAL CHEMISTRY (2006)
A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist
A Lingford-Hughes et al.
PSYCHOPHARMACOLOGY (2005)
Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo Imaging of the dopamine D2 high-affinity state with positron emission tomography
AA Wilson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
G Kelloff et al.
CLINICAL CANCER RESEARCH (2005)
The newer antipsychotics: underlying mechanisms and the new clinical realities
S Kapur et al.
CURRENT OPINION IN PSYCHIATRY (2004)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
PET/CT:: a new imaging technology in nuclear medicine
H Schöder et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
F Courbon et al.
MOVEMENT DISORDERS (2003)
Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597):: A study using positron emission tomography and [11C]raclopride
F Yokoi et al.
NEUROPSYCHOPHARMACOLOGY (2002)
PET studies with carbon-11 radioligands in neuropsychopharmacological drug development
C Halldin et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
The possible role of 5-HT1B/D receptors in psychiatric disorders and their potential as a target for therapy
C Moret et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review
M Laruelle
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
分享论文
